Advanced Biomed Inc. Common Stock (ADVB) vs GT Biopharma, Inc. (GTBP)
A side-by-side comparison of Advanced Biomed Inc. Common Stock and GT Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADVB
Advanced Biomed Inc. Common Stock
$6.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
GTBP
GT Biopharma, Inc.
$6.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ADVB vs GTBP
growth of $100 · dividends reinvested · last 2yADVB -91.3% (-70.5%/yr)GTBP -88.7% (-66.4%/yr)GTBP compounded faster over this window
ADVB GTBP
ADVB vs GTBP: by the numbers
- •ADVB is the larger company ($9M vs $8M market cap).
Metrics side by side
Valuation
| Metric | ADVB | GTBP |
|---|---|---|
| P/B ratio | 0.96 | 2.25 |
Profitability
| Metric | ADVB | GTBP |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -7.36% | -618.74% |
| ROIC | -11.06% | -457.75% |
Growth (annualized)
| Metric | ADVB | GTBP |
|---|---|---|
| Total return CAGR (5Y) | N/A | -73.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.